WO2001034810A3 - Genes essential for microbial proliferation - Google Patents
Genes essential for microbial proliferation Download PDFInfo
- Publication number
- WO2001034810A3 WO2001034810A3 PCT/US2000/030950 US0030950W WO0134810A3 WO 2001034810 A3 WO2001034810 A3 WO 2001034810A3 US 0030950 W US0030950 W US 0030950W WO 0134810 A3 WO0134810 A3 WO 0134810A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acids
- screen
- proliferation
- proteins
- coli
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU20419/01A AU2041901A (en) | 1999-11-09 | 2000-11-09 | Genes essential for microbial proliferation and antisense thereto |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16441599P | 1999-11-09 | 1999-11-09 | |
US60/164,415 | 1999-11-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001034810A2 WO2001034810A2 (en) | 2001-05-17 |
WO2001034810A3 true WO2001034810A3 (en) | 2002-05-10 |
Family
ID=22594383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/030950 WO2001034810A2 (en) | 1999-11-09 | 2000-11-09 | Genes essential for microbial proliferation |
Country Status (3)
Country | Link |
---|---|
US (2) | US6589738B1 (en) |
AU (1) | AU2041901A (en) |
WO (1) | WO2001034810A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7750134B2 (en) * | 2001-11-20 | 2010-07-06 | Sanford-Burnham Medical Research Institute | Nucleic acids encoding microbial SUMO protease homologs |
AU2002351241A1 (en) * | 2001-12-04 | 2003-06-17 | Nereus Pharmaceuticals, Inc. | Methods and apparatus for cell based screening |
WO2004009835A2 (en) * | 2002-07-17 | 2004-01-29 | Merck & Co., Inc. | Method for identifying cellular growth inhibitors |
US20050026189A1 (en) * | 2003-05-29 | 2005-02-03 | Liangsu Wang | Microbial operons |
EP2970976A4 (en) * | 2013-03-15 | 2016-11-02 | Techulon Inc | Antisense molecules for treatment of staphylococcus aureus infection |
US11866728B2 (en) | 2022-01-21 | 2024-01-09 | Renagade Therapeutics Management Inc. | Engineered retrons and methods of use |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998021366A1 (en) * | 1996-11-13 | 1998-05-22 | Qbi Enterprises, Ltd. | Gene identification method |
WO1999002673A2 (en) * | 1997-07-10 | 1999-01-21 | Genesense Technologies, Inc. | Antisense oligonucleotide sequences as inhibitors of microorganisms |
WO2001048209A2 (en) * | 1999-12-23 | 2001-07-05 | Elitra Pharmaceuticals, Inc. | Genes identified as required for proliferation of e. coli |
Family Cites Families (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3327839A1 (en) | 1983-08-02 | 1985-02-14 | Merck Patent Gmbh, 6100 Darmstadt | METHOD AND MEANS FOR SENSITIVITY TESTING OF BACTERIA |
US5190931A (en) | 1983-10-20 | 1993-03-02 | The Research Foundation Of State University Of New York | Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA |
US5272065A (en) | 1983-10-20 | 1993-12-21 | Research Foundation Of State University Of New York | Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA |
US5208149A (en) | 1983-10-20 | 1993-05-04 | The Research Foundation Of State University Of New York | Nucleic acid constructs containing stable stem and loop structures |
ATE81872T1 (en) | 1985-03-15 | 1992-11-15 | James Summerton | STEROREOGULAR POLYNUCLEOTIDE BINDING POLYMERS. |
US4906742A (en) | 1986-07-31 | 1990-03-06 | Whitehead Institute For Biomedical Research | Encoding antigens of M. Leprae |
US5266464A (en) | 1988-02-10 | 1993-11-30 | Ict Pharmaceuticals, Inc. | Method of screening for protein inhibitors and activators |
US5688655A (en) | 1988-02-10 | 1997-11-18 | Ict Pharmaceuticals, Inc. | Method of screening for protein inhibitors and activators |
US4980281A (en) | 1988-02-10 | 1990-12-25 | Housey Gerard M | Method of screening for protein inhibitors and activators |
US5405775A (en) | 1989-02-24 | 1995-04-11 | The University Of Medicine And Dentistry Of New Jersey | Retrons coding for hybrid DNA/RNA molecules |
US5082767A (en) | 1989-02-27 | 1992-01-21 | Hatfield G Wesley | Codon pair utilization |
US5639603A (en) | 1991-09-18 | 1997-06-17 | Affymax Technologies N.V. | Synthesizing and screening molecular diversity |
US5353236A (en) | 1992-04-23 | 1994-10-04 | The Board Of Trustees Of The Leland Stanford University | High-resolution crystallographic modelling of a macromolecule |
WO1994026933A1 (en) | 1993-05-13 | 1994-11-24 | The Board Of Trustees Of The Leland Stanford Junior University | Genetic footprinting: insertional mutagenesis and genetic selection |
US5585277A (en) | 1993-06-21 | 1996-12-17 | Scriptgen Pharmaceuticals, Inc. | Screening method for identifying ligands for target proteins |
US5707798A (en) | 1993-07-13 | 1998-01-13 | Novo Nordisk A/S | Identification of ligands by selective amplification of cells transfected with receptors |
US5739309A (en) * | 1993-07-19 | 1998-04-14 | Gen-Probe Incorporated | Enhancement of oligonucleotide inhibition of protein production, cell proliferation and / or multiplication of infectious disease pathogens |
WO1995006132A2 (en) | 1993-08-27 | 1995-03-02 | Myco Pharmaceuticals, Incorporated | Identifying biologically active agents through culture color change |
US5807522A (en) | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
US5683987A (en) * | 1994-07-12 | 1997-11-04 | The Board Of Regents Of The University Of Nebraska | Therapeutic oligonucleotides targeting the human MDR1 and MRP genes |
US5463564A (en) | 1994-09-16 | 1995-10-31 | 3-Dimensional Pharmaceuticals, Inc. | System and method of automatically generating chemical compounds with desired properties |
KR20050052665A (en) | 1994-12-09 | 2005-06-03 | 임페리얼 컬리지 이노베이션스 리미티드 | Identification of genes |
CA2211131A1 (en) | 1995-01-23 | 1996-08-01 | Microcide Pharmaceuticals, Inc. | Screening for modulators of biomolecules |
AU5939996A (en) | 1995-06-07 | 1996-12-30 | Microcide Pharmaceuticals, Inc. | Methods for evaluation of antimicrobial targets |
US5569588A (en) | 1995-08-09 | 1996-10-29 | The Regents Of The University Of California | Methods for drug screening |
GB9518395D0 (en) | 1995-09-08 | 1995-11-08 | Therexsys Ltd | Plasmid stabilization |
US6037123A (en) | 1995-09-15 | 2000-03-14 | Microcide Pharmaceuticals, Inc. | Methods of screening for compounds active on Staphylococcus aureus target genes |
US6020121A (en) | 1995-09-29 | 2000-02-01 | Microcide Pharmaceuticals, Inc. | Inhibitors of regulatory pathways |
US5858709A (en) | 1996-10-15 | 1999-01-12 | Smithkline Beecham P.L.C. | Fibronectin binding protein B compounds |
CN1177293A (en) | 1995-10-30 | 1998-03-25 | 史密丝克莱恩比彻姆公司 | Method for inhibiting cathepsin K |
US5869604A (en) | 1995-11-09 | 1999-02-09 | Georgia Institute Of Technology | Crystallization and purification of polypeptides |
US5679523A (en) | 1995-11-16 | 1997-10-21 | The Board Of Trustees Of The Leland Stanford Junior University | Method for concurrent disruption of expression of multiple alleles of mammalian genes |
WO1997023642A1 (en) | 1995-12-22 | 1997-07-03 | Microcide Pharmaceuticals, Inc. | Size-based marker identification technology |
GB9526352D0 (en) | 1995-12-22 | 1996-02-21 | Smithkline Beecham Plc | Novel compounds |
GB9526356D0 (en) | 1995-12-22 | 1996-02-21 | Smithkline Beecham Plc | Novel compounds |
US6737248B2 (en) | 1996-01-05 | 2004-05-18 | Human Genome Sciences, Inc. | Staphylococcus aureus polynucleotides and sequences |
GB9600955D0 (en) | 1996-01-17 | 1996-03-20 | Smithkline Beecham Plc | Novel compounds |
AU725716C (en) | 1996-01-23 | 2003-02-20 | Board Of Trustees Of The Leland Stanford Junior University | Methods for screening for transdominant effector peptides and RNA molecules |
US5744460A (en) | 1996-03-07 | 1998-04-28 | Novartis Corporation | Combination for treatment of proliferative diseases |
JP2000511769A (en) | 1996-04-02 | 2000-09-12 | スミスクライン・ビーチャム・コーポレイション | New compound |
WO1997038293A2 (en) | 1996-04-11 | 1997-10-16 | Mitotix, Inc. | Assays and reagents for identifying anti-fungal agents, and uses related thereto |
GB9609018D0 (en) | 1996-05-01 | 1996-07-03 | Smithkline Beecham Plc | Novel compounds |
US5756305A (en) | 1996-05-06 | 1998-05-26 | Millennium Pharmaceuticals, Inc. | Identification of essential survival genes |
AU743007B2 (en) | 1996-06-17 | 2002-01-17 | Essential Therapeutics, Inc. | Screening methods using microbial strain pools |
EP0816511B2 (en) | 1996-06-27 | 2006-06-14 | Clondiag Chip Technologies GmbH | Method of screening substances |
AU3811897A (en) | 1996-07-24 | 1998-02-10 | Oglios Therapeutics, Inc. | Antisense oligonucleotides as antibacterial agents |
DE19630617A1 (en) * | 1996-07-29 | 1998-02-05 | Boehringer Mannheim Gmbh | Positive selection vector based on the caps gene, pCAPs vector and its use |
US6017728A (en) | 1996-08-16 | 2000-01-25 | Smithkline Beecham Corporation | ribH |
US5955275A (en) | 1997-02-14 | 1999-09-21 | Arcaris, Inc. | Methods for identifying nucleic acid sequences encoding agents that affect cellular phenotypes |
US6107071A (en) | 1996-09-24 | 2000-08-22 | Smithkline Beecham Corporation | Histidinol dehydrogenase |
JPH10191990A (en) | 1996-10-15 | 1998-07-28 | Smithkline Beecham Corp | Method for determing gene essentiality in a pathogen |
US5910414A (en) | 1996-10-15 | 1999-06-08 | Smithkline Beecham Corporation | Topoisomerase I of streptococcus pneumoniae |
US6139817A (en) | 1996-10-15 | 2000-10-31 | Smithkline Beecham Corporation | Method for determining gene essentiality in a pathogen |
US5885572A (en) | 1996-10-23 | 1999-03-23 | Smithkline Beecham Corporation | FabH |
WO1998019162A1 (en) | 1996-10-31 | 1998-05-07 | Novalon Pharmaceutical Corporation | Identification of drugs using complementary combinatorial libraries |
ES2281917T3 (en) | 1996-11-06 | 2007-10-01 | Smithkline Beecham Corporation | PROCEDURES TO IDENTIFY GENES FOR THE GROWTH OF AN ORGANISM. |
US5869290A (en) | 1996-11-21 | 1999-02-09 | Smithkline Beecham Corporation | Cayae1 polynucleotides |
US5786197A (en) | 1996-11-25 | 1998-07-28 | Smithkline Beecham Corporation | lep |
SK83499A3 (en) | 1996-12-24 | 2000-01-18 | Kaba Schliesssysteme Ag | Locking device |
WO1998042854A1 (en) | 1997-03-27 | 1998-10-01 | The Board Of Trustees Of The Leland Stanford Junior University | Functional genomic screen for rna regulatory sequences and interacting molecules |
DE19713572A1 (en) | 1997-04-02 | 1998-10-22 | Hoechst Ag | Method for screening antifungal substances |
WO1998050554A2 (en) | 1997-05-06 | 1998-11-12 | Human Genome Sciences, Inc. | Enterococcus faecalis polynucleotides and polypeptides |
US6204019B1 (en) | 1997-06-04 | 2001-03-20 | Smithkline Beecham Corporation | Sec A2 from Streptococcus pneumoniae |
EP0891984A3 (en) | 1997-06-20 | 2000-01-19 | Smithkline Beecham Corporation | Nucleic acid encoding streptococcus pneumoniae response regulator |
CA2236452A1 (en) | 1997-07-01 | 1999-01-01 | Smithkline Beecham Corporation | Gida1 |
EP0889123A3 (en) | 1997-07-03 | 2001-10-10 | Smithkline Beecham Corporation | MurC gene of Staphylococcus aureus coding for UDP-N-acetylmuramate:L-alanine Ligase |
US5994101A (en) | 1997-07-18 | 1999-11-30 | Smithkline Beecham Corporation | DNA encoding gidA1 polypeptides |
US5939298A (en) | 1997-07-23 | 1999-08-17 | Smithkline Beecham Corporation | DNA encoding phenylalanyl tRNA synthetase alpha sub-unit from chlamydi a trachomatis |
AU8678198A (en) | 1997-08-01 | 1999-02-22 | Novalon Pharmaceutical Corporation | Method of identifying and developing drug leads |
US5866370A (en) | 1997-08-05 | 1999-02-02 | Smithkline Beecham Corporation | Aminopeptidase |
US6258578B1 (en) | 1997-08-11 | 2001-07-10 | Smithkline Beecham Corporation | His5 |
US6284515B1 (en) | 1997-09-03 | 2001-09-04 | Smithkline Beecham Corporation | Signal recognition particle polypeptides and polynucleotides |
US6300318B1 (en) | 1997-09-16 | 2001-10-09 | Peter E. Nielsen | Antibacterial and antibiotic methods using peptide nucleic acids and pharmaceutical compositions therefor |
EP0905247A3 (en) | 1997-09-25 | 1999-10-20 | Smithkline Beecham Corporation | MurF polynucleotides and polypeptides from Staphylococcus |
WO1999023244A1 (en) | 1997-11-03 | 1999-05-14 | Small Molecule Therapeutics, Inc. | Methods and compositions for modulation of bacterial topoisomerase enzymes |
US6228579B1 (en) | 1997-11-14 | 2001-05-08 | San Diego State University Foundation | Method for identifying microbial proliferation genes |
US6100069A (en) | 1997-11-20 | 2000-08-08 | Smithkline Beecham Corporation | DNA encoding streptococcus pneumoniae trigger factor polypeptides |
EP1034296A1 (en) | 1997-11-25 | 2000-09-13 | Smithkline Beecham Corporation | ribH POLYPEPTIDES AND POLYNUCLEOTIDES |
EP1034260B1 (en) | 1997-12-05 | 2003-06-04 | Europäisches Laboratorium Für Molekularbiologie (Embl) | Novel dna cloning method relying on the e. coli rece/rect recombination system |
WO1999033871A2 (en) | 1997-12-31 | 1999-07-08 | Millennium Pharmaceuticals, Inc. | Essential bacterial genes and their use |
CA2317653A1 (en) | 1998-01-09 | 1999-07-15 | Cubist Pharmaceuticals, Inc. | Method for identifying validated target and assay combinations |
JP2002508972A (en) | 1998-01-16 | 2002-03-26 | ファルマシア・アンド・アップジョン・カンパニー | Autonomous control system for identifying microbial genes as possible antimicrobial targets using tetracycline-regulatable elements |
AU2795799A (en) | 1998-02-26 | 1999-09-15 | Guennadi V. Glinskii | Antibacterial drugs, methods for their design and methods for their use |
US6077682A (en) | 1998-03-19 | 2000-06-20 | University Of Medicine And Dentistry Of New Jersey | Methods of identifying inhibitors of sensor histidine kinases through rational drug design |
US6248525B1 (en) | 1998-03-30 | 2001-06-19 | Yale University | Method for identifying essential or functional genes |
US6344201B1 (en) | 1998-03-31 | 2002-02-05 | Anthony T. Maurelli | Methods of identifying bacterial genes that are incompatible with bacterial pathogenicity, and the use of such genes, such as cadA, to reduce pathogenicity in a bacteria or to combat pathogenic bacterial infections |
US5965352A (en) | 1998-05-08 | 1999-10-12 | Rosetta Inpharmatics, Inc. | Methods for identifying pathways of drug action |
US6156526A (en) | 1998-07-21 | 2000-12-05 | The Rockerfeller University | Crystal of a Ras-Sos complex and methods of use thereof |
US6174678B1 (en) | 1998-10-23 | 2001-01-16 | Small Molecule Therapeutics, Inc. | Methods and compositions for modulation of bacterial topoisomerase enzymes |
-
2000
- 2000-11-09 US US09/711,164 patent/US6589738B1/en not_active Expired - Fee Related
- 2000-11-09 WO PCT/US2000/030950 patent/WO2001034810A2/en active Application Filing
- 2000-11-09 AU AU20419/01A patent/AU2041901A/en not_active Abandoned
-
2002
- 2002-10-31 US US10/287,274 patent/US20030181408A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998021366A1 (en) * | 1996-11-13 | 1998-05-22 | Qbi Enterprises, Ltd. | Gene identification method |
WO1999002673A2 (en) * | 1997-07-10 | 1999-01-21 | Genesense Technologies, Inc. | Antisense oligonucleotide sequences as inhibitors of microorganisms |
WO2001048209A2 (en) * | 1999-12-23 | 2001-07-05 | Elitra Pharmaceuticals, Inc. | Genes identified as required for proliferation of e. coli |
Non-Patent Citations (13)
Title |
---|
AUSTIN A E ET AL: "Genetic analysis of lipopolysaccharide core biosynthesis by Escherichia coli k12 insertion mutagenesis of the RFA locus", JOURNAL OF BACTERIOLOGY,WASHINGTON, DC,US, vol. 172, no. 9, September 1990 (1990-09-01), pages 5312 - 5325, XP000926028, ISSN: 0021-9193 * |
BLATTNER ET AL.: "The complete genome sequence of Escherichia coli K-12", SCIENCE, vol. 277, 5 September 1997 (1997-09-05), pages 1453 - 1462, FIFURES, XP002923023 * |
DATABASE EM_PRO [online] EMBL; 29 January 1997 (1997-01-29), BLATTNER ET AL.: "Escherichia coli K12 MG1655 section 101 of 400 of the complete genome", XP002181472, retrieved from EBI accession no. ECAE211 Database accession no. AE000211 * |
DATABASE EM_PRO [online] EMBL; 29 January 1997 (1997-01-29), BLATTNER ET AL.: "Escherichia coli K12 MG1655 section 305 of 400 of the complete genome", XP002181474, retrieved from EBI accession no. ECAE415 Database accession no. AE000415 * |
DATABASE EM_PRO [online] EMBL; 30 December 1994 (1994-12-30), PLUNKETT, G: "Escherichia coli K-12 chromosomal region from 67.4 to 76 minutes", XP002181477, retrieved from EBI accession no. ECUW67 Database accession no. U18997 * |
DATABASE EM_PRO [online] EMBL; 31 October 1996 (1996-10-31), OSHIMA ET AL.: "Escherichia coli genomic DNA (25.2-25.6 min)", XP002181476, retrieved from EBI accession no. ECD747 Database accession no. D90747 * |
DATABASE SWALL [online] 1 November 1995 (1995-11-01), BLATTNER ET AL.: "Hypothetical 79.5 kDa protein in MRCA-PCKA intergenic region (O711)", XP002181475, retrieved from EBI accession no. YRFF_ECOLI Database accession no. P45800 * |
DATABASE SWALL [online] 15 July 1998 (1998-07-15), BLATTNER ET AL.: "Hypothetical protein YCFS precursor", XP002181473, retrieved from EBI accession no. YCFS_ECOLI Database accession no. P75954 * |
DNA RES., vol. 3, 1996, pages 137 - 155, XP001040039 * |
LEE N G ET AL: "Molecular cloning and characterization of the nontypable Haemophilus influenzae-2019 rfaE gene required for lipopolysaccharide biosynthesis", INFECTION AND IMMUNITY,AMERICAN SOCIETY FOR MICROBIOLOGY. WASHINGTON,US, vol. 63, no. 3, 1995, pages 818 - 824, XP000953326, ISSN: 0019-9567 * |
POST L E ET AL: "NUCLEOTIDE SEQUENCE OF THE RIBOSOMAL PROTEIN GENE CLUSTER ADJACENT TO THE GENE FOR RNA POLYMERASE SUBUNIT BETA IN ESCHERICHIA COLI", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE USA,US,NEW YORK, NY, vol. 76, no. 4, 1 April 1979 (1979-04-01), pages 1697 - 1701, XP000574791 * |
VALVANO M A ET AL: "The rfaE gene from Escherichia coli encodes a bifunctional protein involved in biosynthesis of the lipopolysaccharide core precursor ADP-L-glycero-D-manno-heptose", JOURNAL OF BACTERIOLOGY,WASHINGTON, DC,US, vol. 182, no. 2, January 2000 (2000-01-01), pages 488 - 497, XP000926030, ISSN: 0021-9193 * |
VAN HEESWIJK W C ET AL: "The genes of the glutamine synthetase adenylylation cascade are not regulated by nitrogen in Escherichia coli", MOLECULAR MICROBIOLOGY,BLACKWELL SCIENTIFIC, OXFORD,GB, vol. 9, no. 3, 1993, pages 443 - 457, XP000926027, ISSN: 0950-382X * |
Also Published As
Publication number | Publication date |
---|---|
US6589738B1 (en) | 2003-07-08 |
WO2001034810A2 (en) | 2001-05-17 |
AU2041901A (en) | 2001-06-06 |
US20030181408A1 (en) | 2003-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001048209A3 (en) | Genes identified as required for proliferation of e. coli | |
WO2002077183A9 (en) | Identification of essential genes in microorganisms | |
WO2000044906A3 (en) | GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI) | |
WO2001070955A8 (en) | Identification of essential genes in prokaryotes | |
WO2000044928A3 (en) | Materials and methods for the purification of polyelectrolytes | |
MXPA02012743A (en) | Il-17 molecules and uses thereof. | |
WO2003056021A3 (en) | Modified tetracycline repressor protein compositions and methods of use | |
WO2003040681A3 (en) | Genes coding for metabolic pathway proteins | |
WO2001034810A3 (en) | Genes essential for microbial proliferation | |
AU1727597A (en) | Purified sr-p70 protein | |
EP1178052A3 (en) | Genes identified as required for proliferation in Escherichia coli | |
AU2001238064A1 (en) | 18477, a human protein kinase and uses therefor | |
WO2002042437A3 (en) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | |
WO2002034922A3 (en) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | |
PL374550A1 (en) | Il-17 like molecules and uses thereof | |
WO2001036478A3 (en) | Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides | |
WO2002072632A3 (en) | Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. | |
WO2002008266A3 (en) | Complete nucleotide sequence of staphylococcus aureus ribosomal protein s16 gene and methods for the identification of antibacterial substances | |
AU2002258630A1 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
WO2002050545A3 (en) | Compositions and methods involving staphylococcus aureus protein staau-r9 | |
WO2002022795A3 (en) | Isolated human kinase proteins, nucleic acid molecules and uses thereof | |
WO2003025004A3 (en) | Purified bacterial polypeptides involved in nucleic acid processing | |
AU2002323612A1 (en) | Novel clark protein and nucleic acid molecules and uses therefor | |
WO2003035858A3 (en) | Bacterial polypeptides involved in nucleic acid processing | |
WO2004081206A3 (en) | Novel polypeptides encoded by essential bacterial genes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |